Clinical trialNCT05948865RecruitingPhase 1Interventional

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

SponsorConjupro Biotherapeutics, Inc.Enrollment132CancerCancer, Lung

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

Cross Cancer Institute
Edmonton, Alberta, Canada
Quincy Chu, MD
Recruiting
Juravinski Cancer Centre
Hamilton, Ontario, Canada
Rosalyn Juergens, MD, PhD
Recruiting
Princess Margaret Cancer Centre - University Health Network
Toronto, Ontario, Canada
Laswson Eng, MD
Recruiting

United States

Usc Norris Comprehensive Cancer Center
Los Angeles, California, United States
Jacob Thomas, MD
Recruiting
Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
Carlos R Becerra, MD
Recruiting
Ucla Hematology/oncology - Santa Monica
Santa Monica, California, United States
Lee S. Rosen, MD
Recruiting
Sarah Cannon Research Institute (scri) at Healthone
Denver, Colorado, United States
Gerald Falchook, MD, MS
Recruiting
Adventhealth Cancer Institute
Celebration, Florida, United States
Guru P. Sonpavde, MD
Recruiting
Florida Cancer Specialists
Sarasota, Florida, United States
Manish Patel, MD
Recruiting
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
Konstantin Dragnev, MD
Recruiting
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
Anshu Giri, MD
Recruiting
Scri Oncology Partners
Nashville, Tennessee, United States
Melissa L Johnson, MD
Recruiting
Next Dallas
Dallas, Texas, United States
Recruiting
Next Virginia
Fairfax, Virginia, United States
Alex Spira, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 6 Jun 2023
Primary completion: 31 May 2027
Completion: 31 Aug 2027
Last update posted: 20 Mar 2026
Registered enrollment: 132
Registry id: NCT05948865

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.